RaySearch Laboratories AB (publ) (RSLBF)
OTCMKTS
· Delayed Price · Currency is USD
22.50
-1.40 (-5.86%)
Apr 23, 2025, 4:00 PM EDT
RaySearch Laboratories AB Revenue
In the year 2024, RaySearch Laboratories AB had annual revenue of 1.19B SEK with 16.62% growth. RaySearch Laboratories AB had revenue of 322.67M in the quarter ending December 31, 2024, with 7.68% growth.
Revenue
1.19B SEK
Revenue Growth
+16.62%
P/S Ratio
8.38
Revenue / Employee
2.87M SEK
Employees
416
Market Cap
902.14M USD
Revenue Chart
* This company reports financials in SEK.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.19B | 169.87M | 16.62% |
| Dec 31, 2023 | 1.02B | 178.51M | 21.16% |
| Dec 31, 2022 | 843.65M | 201.98M | 31.48% |
| Dec 31, 2021 | 641.67M | -9.94M | -1.53% |
| Dec 31, 2020 | 651.61M | -89.97M | -12.13% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SS Innovations International | 20.65M |
| Endo Inc. | 1.76B |
| Veradigm | 588.02M |
| Northwest Biotherapeutics | 1.38M |
| Elite Pharmaceuticals | 70.00M |
| Glass House Brands | 200.90M |
| BioStem Technologies | 301.83M |
| American Oncology Network | 1.76B |
RaySearch Laboratories AB News
- 5 weeks ago - Completed placing of shares in RaySearch Laboratories AB (publ) - PRNewsWire
- 5 weeks ago - Contemplated placement of existing shares in RaySearch Laboratories AB - PRNewsWire
- 2 months ago - RaySearch Laboratories reports Q4 results - Seeking Alpha
- 2 months ago - RaySearch Laboratories: Year-end report 2024 - PRNewsWire
- 5 months ago - RaySearch Laboratories to present ongoing development in liver ablation therapy* at RSNA 2024 - PRNewsWire
- 5 months ago - RaySearch Laboratories AB (RSLBF) Q3 2024 Earnings Call Highlights: Record Revenue and ... - GuruFocus
- 5 months ago - Q3 2024 RaySearch Laboratories AB (publ) Earnings Call Transcript - GuruFocus
- 5 months ago - RaySearch Laboratories: Interim report July - September 2024 - PRNewsWire